Updated Jul 16, 2026
Butler John P. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $87K. Lifetime open-market sales: $474K.
John P. Butler is associated with Akebia Therapeutics, Inc., a biopharmaceutical company focused on developing therapies for kidney disease. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-05 | AKBA | Akebia Therapeutics, Inc. | P — Open-market purchase | 69.3K | $1.25 | $87K |
| 2026-02-04 | AKBA | Akebia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 83.7K | $1.39 | $116K |
| 2026-02-04 | AKBA | Akebia Therapeutics, Inc. | A — Grant or award [10b5-1] | 175.2K | $1.41 | $247K |
| 2026-02-04 | AKBA | Akebia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 114.9K | $1.39 | $160K |
| 2026-02-04 | AKBA | Akebia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 96.1K | $1.39 | $134K |
| 2026-02-04 | AKBA | Akebia Therapeutics, Inc. | S — Open-market sale [10b5-1] | 46.7K | $1.39 | $65K |
| 2026-02-03 | AKBA | Akebia Therapeutics, Inc. | A — Grant or award | 743.0K | $0.00 |
John P. Butler is associated with Akebia Therapeutics, Inc., a biopharmaceutical company focused on developing therapies for kidney disease. Specific details about his role and contributions to the company are not widely documented.…
Recorded transactions: 1 open-market purchases ($87K) and 4 open-market sales ($474K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Butler John P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.